1,402 results match your criteria: "Barcelona Hospital[Affiliation]"

Trends in antiseizure medication prescription in Idiopathic generalized epilepsy over the last 10 years.

Epilepsy Behav

November 2024

Epilepsy Unit, Neurology Department, Medicine Department, Universitat Autònoma de Barcelona. Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, 08035, Barcelona, Spain; Research group on Status Epilepticus and Acute Seizures, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, Vall d'Hebron Hospital Campus, 08035, Barcelona, Spain.

Background: Idiopathic Generalized Epilepsies (IGE) are a subset of syndromes defined by the International League against Epilepsy (ILAE) with the particularity to respond to a narrow number of ASMs and particularly to valproic acid (VPA). Recommendations have changed in the last decade. We aimed to describe changes in antiseizure medication (ASM) in adult IGE over the last 10 years.

View Article and Find Full Text PDF

Letter: Why Assessment of ChILI Severity Accurately Matters?

Aliment Pharmacol Ther

January 2025

Nottingham Digestive Diseases Centre, Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK.

View Article and Find Full Text PDF

Macrophages are critical effectors of antibody therapies for lymphoma, but the best targets for this purpose remain unknown. Here, we sought to define a comprehensive repertoire of cell surface antigens that can be targeted to stimulate macrophage-mediated destruction of B-cell lymphoma. We developed a high-throughput assay to screen hundreds of antibodies for their ability to provoke macrophages to attack B-cell lymphoma cells.

View Article and Find Full Text PDF

Association of Liver Damage and Quasispecies Maturity in Chronic HCV Patients: The Fate of a Quasispecies.

Microorganisms

October 2024

Liver Diseases-Viral Hepatitis, Liver Unit, Vall d'Hebron Institut of Research (VHIR), Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.

Viral diversity and disease progression in chronic infections, and particularly how quasispecies structure affects antiviral treatment, remain key unresolved issues. Previous studies show that advanced liver fibrosis in long-term viral infections is linked to higher rates of antiviral treatment failures. Additionally, treatment failure is associated with high quasispecies fitness, which indicates greater viral diversity and adaptability.

View Article and Find Full Text PDF

Impact of SARS-CoV-2 vaccination in patients with vascular liver diseases: Observations from a VALDIG multicenter study.

JHEP Rep

December 2024

Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clínic, Institut de InvestigacionsBiomèdiques August Pi iSunyer (IDIBAPS), Departament de Medicina I Ciències de la Salut - University of Barcelona, Barcelona. CIBEREHD (Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas). Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN-Rare Liver), Spain.

Background & Aims: Patients with vascular liver diseases (VLD) are at higher risk of both severe courses of COVID-19 disease and thromboembolic events. The impact of SARS-CoV-2 vaccination in patients with VLD has not been described and represents the aim of our study.

Methods: International, multicenter, prospective observational study in patients with VLD analyzing the incidence of COVID-19 infection after vaccination, severity of side effects, occurrence of thromboembolic events and hepatic decompensation.

View Article and Find Full Text PDF

Incidence and chronology of atrioventricular block and outcomes after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.

Rev Esp Cardiol (Engl Ed)

November 2024

Unitat d'Arritmies, Servei de Cardiologia, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain. Electronic address:

View Article and Find Full Text PDF
Article Synopsis
  • TRAF3 is an adaptor protein involved in immune signaling pathways, and deficiencies in TRAF3 can lead to serious health issues, like recurrent infections and autoimmune conditions.
  • A recent study reanalyzed genetic data from patients with immune disorders and discovered three new cases of TRAF3 mutations, which had previously been misdiagnosed as common variable immunodeficiency (CVID).
  • These findings highlight the importance of targeted genetic reanalysis in understanding different clinical presentations of TRAF3 deficiency, and they provide new insights for further research on immune-related diseases.
View Article and Find Full Text PDF

The redirection of T lymphocytes against tumor-associated or tumor-specific antigens, using bispecific antibodies or chimeric antigen receptors (CAR), has shown therapeutic success against certain hematological malignancies. However, this strategy has not been effective against solid tumors. Here, we describe the development of CAR T cells targeting p95HER2, a tumor-specific antigen found in HER2-amplified solid tumors.

View Article and Find Full Text PDF

Over the past decades, health care systems have significantly evolved due to aging populations, chronic diseases, and higher-quality care expectations. Concurrently with the added health care needs, information and communications technology advancements have transformed health care delivery. Technologies such as telemedicine, electronic health records, and mobile health apps promise enhanced accessibility, efficiency, and patient outcomes, leading to more personalized, data-driven care.

View Article and Find Full Text PDF

Three-year survival follow-up of patients with gastrointestinal cancer treated during the COVID-19 pandemic in Spain: data from the PANDORA-TTD20 study.

Oncologist

November 2024

Medical Oncology Department, Hospital Universitario Reina Sofía, Universidad de Córdoba, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), CIBERONC, Instituto de Salud Carlos III (ISCIII), Córdoba, 14004, Spain.

Introduction: The initial SARS-CoV-2 pandemic wave in Spain in 2020 precipitated significant paradigm shifts in gastrointestinal oncology patient management. This study captures the "Zeitgeist" of this period by analyzing adaptive strategies, treatment modifications, and survival outcomes, leveraging a 3-year follow-up perspective to extract insights from this unprecedented experience.

Methods: We conducted a multicenter, retrospective cohort study utilizing the RETUD-TTD registry, encompassing 703 patients across 19 Spanish centers in April 2020.

View Article and Find Full Text PDF

Follicular lymphoma (FL) usually requires multiple lines of therapy and disease control remains largely insufficient with conventional chemoimmunotherapy. Several T-cell redirecting strategies recently approved in the relapsed/refractory setting have the potential to improve outcomes and change the treatment algorithm in FL. This review focuses on the role of chimeric antigen receptor T-cells and bispecific antibodies in FL, paying special attention to sequencing approaches and future directions.

View Article and Find Full Text PDF

DSTYK Inhibition Sensitizes Non-Small Cell Lung Cancer To Taxane-Based Chemotherapy.

J Thorac Oncol

November 2024

Program in Solid Tumors, CIMA-University of Navarra, Pamplona, Spain; Consorcio de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain; Navarra Health Research Institute (IDISNA), Pamplona, Spain; Department of Biochemistry and Genetics, School of Sciences, University of Navarra, Pamplona, Spain. Electronic address:

Chemotherapy continues to be the standard treatment for patients non-eligible to targeted or immune-based therapies; however, treatment resistance remains a major clinical challenge. We previously found that expression levels of DSTYK, a poorly explored dual serine/threonine and tyrosine kinase frequently amplified in cancer, identifies lung cancer patients exhibiting poor response to immune checkpoint inhibitors and showed that its inhibition sensitizes to immunotherapy. Seeking to explore the potential of DSTYK targeting in additional indications, we investigated the functional relevance and actionability of DSTYK in lung cancer chemoresistance.

View Article and Find Full Text PDF

Liver stiffness measurement predicts clinical outcomes in autoimmune hepatitis.

JHEP Rep

November 2024

Liver Unit, Hospital Clínic Barcelona, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Universitat de Barcelona, Barcelona, Spain.

Background & Aims: Liver stiffness measurement (LSM) has been shown to adequately predict outcomes in patients with liver disease. However, the value of LSM as a predictor of disease progression in autoimmune hepatitis (AIH) remains to be determined. This study aimed to evaluate the role of LSM as a predictor of disease progression and decompensation of cirrhosis in patients with AIH.

View Article and Find Full Text PDF

Oncogenic role of PMEPA1 and its association with immune exhaustion and TGF-β activation in HCC.

JHEP Rep

November 2024

Liver Cancer Translational Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain.

Article Synopsis
  • TGF-β is implicated in promoting cancer development, and the study investigates a specific protein's role in hepatocellular carcinoma (HCC), finding its overexpression linked to aggressive cancer features.
  • The research involved analyzing tumor data from a large number of HCC patients and using mouse models to explore molecular effects, revealing a connection between the protein’s levels and immune system suppression.
  • The findings suggest that overexpressing this protein contributes to tumor growth and poor patient outcomes, highlighting its potential as a target for cancer treatment.
View Article and Find Full Text PDF

Facial Hypomimia, Oculomotor Paralysis, and Ataxia Associated With GAD65 and Glycine Receptor Antibodies in a Child.

Neurology

December 2024

From the Pediatric Neurology (Z.O.Z.C., A.E.C., A.G.R., M.J.M.-G.), Cruces University Hospital, Bizkaia; Pediatric Neurology (A.F.-R.), Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona; Pediatric Neurology (G.O.-C.), Hospital Universitari Parc de Taulí, Sabadell; and Pediatric Neuroimmunology Unit (T.A.), Neurology Department, Research Institute of Sant Joan de Deu Children's Hospital, University of Barcelona, Spain.

View Article and Find Full Text PDF

Hepatitis E as a trigger for Acute-on-Chronic Liver Failure.

Clin Mol Hepatol

November 2024

Liver Unit, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.

Acute hepatitis E virus (HEV) infection is typically self-limiting and has a favourable prognosis. However, certain populations such as patients with pre-existing chronic liver disease may experience severe manifestations, including progression to acute-on-chronic liver failure (ACLF). Among viral hepatitis types, hepatitis A, E, and B are major causes of ACLF.

View Article and Find Full Text PDF

Introduction: Pharmacogenetics (PGx) has the potential to improve patient care, allowing to transform medical interventions by providing personalized therapeutic strategies. Scientific evidence supports the use of PGx in clinical practice and international organizations are developing clinical guidelines to facilitate the utilization of PGx testing. However, clinical implementation of PGx is limited and unequal worldwide.

View Article and Find Full Text PDF

The ultrasound-guided cervical plexus plane (US-CPP) block has proven effective in humans; yet its application in dogs remains unexplored. This study aimed to describe a novel US-CPP approach in canines. A local sonoanatomy was mapped, the injection technique was tested, and a gross anatomical dissection (GAD) was performed on one cadaver.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to compare the Asthma Control Test (ACT) and COPD Assessment Test (CAT) in relation to the severity of asthma-COPD overlap among smokers and former smokers in Spain.
  • Out of 157 patients, both tests showed a strong correlation, but the ACT had a better predictive value for exacerbations than the CAT.
  • Factors like anxiety, depression, and dyspnoea were linked to both tests, while age and other specific health scores were only associated with one of the tests.
View Article and Find Full Text PDF
Article Synopsis
  • GLP1 receptor agonists (GLP1-RAs) are medications that mimic the incretin hormone GLP1, first used for diabetes in 2005 and for obesity in 2014.
  • Recent studies suggest that GLP1-RAs may also help slow kidney disease progression, leading to the Flow study, which examined semaglutide's effects.
  • The Flow study confirmed semaglutide's benefits on kidney health, but the exact mechanisms of how GLP1-RAs affect renal function remain unclear, necessitating further research.
View Article and Find Full Text PDF

Newborn screening for SCID and severe T lymphocytopenia in Europe.

J Allergy Clin Immunol

November 2024

Laboratory for Paediatric Immunology, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands. Electronic address:

Article Synopsis
  • Newborn screening (NBS) programs in Europe started in the 1960s, expanding recently to include testing for severe combined immunodeficiency (SCID) through T-cell receptor excision circles (TRECs).
  • A survey sent to 46 European countries collected comprehensive data, with 38 countries responding, revealing that 17 have already implemented TREC-based NBS.
  • The findings indicate a need to reassess the definition of the target disease to include conditions beyond SCID and highlight the importance of international collaboration for improving universal TREC-based screening.
View Article and Find Full Text PDF
Article Synopsis
  • Necrotizing enterocolitis (NEC) significantly contributes to neonatal morbidity and mortality, and this study investigates whether congenital cardiopathy (CC) exacerbates the gastrointestinal and overall prognosis of NEC.
  • The analysis included 190 neonates with NEC, comparing those with congenital cardiopathy to those without, revealing that CC patients had more frequent hemodynamic shock and longer hospital stays, along with higher mortality rates.
  • Despite these differences in stability and outcomes, the need for surgery and intestinal involvement were similar between CC and non-CC patients.
View Article and Find Full Text PDF